Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
6.03
-0.15 (-2.43%)
Dec 1, 2025, 12:43 PM EST - Market open
Cybin Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
300.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 686.88K | - | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CYBN News
- 17 days ago - Cybin Inc. (CYBN) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 18 days ago - Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights - Business Wire
- 19 days ago - Cybin to Participate in the Jefferies Global Healthcare Conference in London - Business Wire
- 25 days ago - Cybin to Announce Second Quarter Financial Results and Provide Business Update on November 13, 2025 - Business Wire
- 26 days ago - Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - Business Wire
- 4 weeks ago - Cybin to Participate at the 2025 Milken Institute Future of Health Summit - Business Wire
- 4 weeks ago - Cybin Announces Closing of $175 Million Registered Direct Offering - Business Wire
- 4 weeks ago - Cybin Announces $175 Million Registered Direct Offering - Business Wire